Peer-influenced content. Sources you trust. No registration required. This is HCN.

The American Journal of Endocannabinoid Medicine’s (AJEM) mission is to educate healthcare professionals on medicines that engage with the endocannabinoid system (ECS). By presenting clinical research on the role of the ECS in achieving homeostasis and as a therapeutic target, AJEM seeks to improve the practice of evidence-based cannabinoid medicine. AJEM publishes peer-reviewed original research manuscripts and research interpretation, news, and opinion pieces from thought leaders in the field. AJEM’s renowned Editorial Board members assist in the peer-review process and are a diverse group of experts with experience in various cannabinoid medicine disciplines.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form